Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Post Ocular Surgical Inflammation and Pain
Clinical Trial
NCT02034019Last updated: 12/4/2025
OCUL
OCULAR THERAPEUTIX, INC